Clindamycin



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 24.8%
Cellulitis 11.6%
Tooth Infection 8.2%
Infection 6.9%
Prophylaxis 4.7%
Tooth Abscess 4.5%
Staphylococcal Infection 4.4%
Hypertension 4.2%
Pain 3.5%
Mastitis 3.4%
Antibiotic Prophylaxis 2.9%
Localised Infection 2.7%
Muscular Weakness 2.5%
Sinusitis 2.5%
Tooth Extraction 2.5%
Endodontic Procedure 2.3%
Gouty Arthritis 2.3%
Infection Prophylaxis 2.2%
Vitamin Supplementation 2.0%
Acne 1.8%
Rash 12.4%
Diarrhoea 10.0%
Vomiting 8.6%
Acute Generalised Exanthematous Pustulosis 6.6%
Clostridium Difficile Colitis 6.6%
Weight Decreased 6.6%
Renal Failure Acute 5.2%
Drug Interaction 4.8%
Urticaria 4.8%
Nausea 4.1%
Malaise 3.4%
Rash Generalised 3.4%
Swelling Face 3.4%
Pruritus 3.1%
Stevens-johnson Syndrome 3.1%
Tubulointerstitial Nephritis 3.1%
Vasculitis Necrotising 3.1%
Pyrexia 2.8%
Clostridial Infection 2.4%
Liver Injury 2.4%
Secondary
Product Used For Unknown Indication 35.5%
Drug Abuse 9.5%
Drug Use For Unknown Indication 6.5%
Pyrexia 6.1%
Sinusitis 4.6%
Pharyngitis 4.0%
Cellulitis 3.8%
Headache 3.6%
Ill-defined Disorder 3.3%
Hypertension 3.1%
Foetal Exposure During Pregnancy 3.0%
Pain 2.5%
Prophylaxis 2.4%
Hiv Infection 2.1%
Tooth Infection 2.1%
Infection 1.8%
Acne 1.6%
Pneumonia 1.5%
Neutropenic Sepsis 1.5%
Agitation 1.4%
Rash 8.1%
Vomiting 8.1%
Weight Decreased 7.1%
Completed Suicide 6.6%
Renal Failure Acute 6.1%
Toxic Epidermal Necrolysis 6.1%
Pyrexia 5.6%
Urticaria 5.6%
Ventricular Extrasystoles 5.6%
Wheezing 5.1%
Pseudomembranous Colitis 4.0%
White Blood Cell Count Decreased 4.0%
Acute Generalised Exanthematous Pustulosis 3.5%
Death 3.5%
Drug Hypersensitivity 3.5%
Drug Ineffective 3.5%
Drug Interaction 3.5%
International Normalised Ratio Increased 3.5%
Liver Injury 3.5%
Stevens-johnson Syndrome 3.5%
Concomitant
Product Used For Unknown Indication 36.3%
Drug Use For Unknown Indication 10.8%
Pain 7.7%
Hypertension 5.3%
Multiple Myeloma 4.9%
Prophylaxis 4.3%
Acne 3.5%
Rheumatoid Arthritis 2.8%
Hiv Infection 2.6%
Contraception 2.6%
Depression 2.3%
Nausea 2.2%
Osteoporosis 2.2%
Breast Cancer 2.2%
Infection 2.0%
Metastases To Bone 2.0%
Anxiety 1.9%
Pyrexia 1.5%
Diabetes Mellitus 1.5%
Rash 1.5%
Weight Decreased 17.5%
Vomiting 13.0%
Pulmonary Embolism 7.2%
Sepsis 6.3%
Pain 5.2%
Tooth Extraction 4.5%
Vision Blurred 4.4%
Wound Infection Staphylococcal 4.4%
Urinary Tract Infection 4.2%
Weight Increased 3.8%
Deep Vein Thrombosis 3.4%
Nausea 3.2%
Rash 3.2%
Thrombocytopenia 3.2%
Pneumonia 3.1%
White Blood Cell Count Decreased 3.1%
Renal Failure Acute 2.9%
Anxiety 2.5%
Death 2.5%
Pyrexia 2.5%
Interacting
Pain 10.4%
Depression 9.0%
Hypertension 9.0%
Subcutaneous Abscess 9.0%
Antibiotic Prophylaxis 6.0%
Drug Use For Unknown Indication 6.0%
Gouty Arthritis 6.0%
Nosocomial Infection 6.0%
Staphylococcal Infection 6.0%
Abdominal Pain 3.0%
Anaemia 3.0%
Ankylosing Spondylitis 3.0%
Asthma 3.0%
Atrial Fibrillation 3.0%
Cellulitis 3.0%
Coronary Artery Disease 3.0%
Dyspepsia 3.0%
Extrapyramidal Disorder 3.0%
Gastrooesophageal Reflux Disease 3.0%
Helicobacter Gastritis 3.0%
Drug Interaction 29.4%
Retroperitoneal Haemorrhage 11.8%
Stevens-johnson Syndrome 11.8%
Tremor 11.8%
White Blood Cell Count Decreased 11.8%
Clostridium Difficile Colitis 5.9%
Pneumonia Aspiration 5.9%
Urinary Tract Infection Bacterial 5.9%
Withdrawal Syndrome 5.9%